Caliper Life Sciences Inc. 

(Public, NASDAQ:CALP)   Watch this stock   
Find more results for CALP
Nov 9, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 9, 2009
Q3 2009 Earnings Release
Sep 22, 2009
UBS Global Life Sciences Conference
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -12.62% -50.94%
Operating margin -11.97% -51.87%
EBITD margin - -42.98%
Return on average assets -12.30% -38.91%
Return on average equity -23.41% -62.68%
Employees 489 -

Address

68 Elm Street
Hopkinton, MA 01748
United States - Map
+1-508-4359500 (Phone)
+1-508-4353439 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Caliper Life Sciences Inc. discussed on blogs

Caliper Life Sciences Inc. discussions

  View all discussions »

Description

Caliper Life Sciences, Inc. (Caliper), develops and sells products and services to the life sciences research community, a customer base that includes pharmaceutical and biotechnology companies, and government and other research institutions. The Company offers an array of products and services, many based on enabling technologies that address critical experimental needs in drug discovery and pre-clinical development, and related processes including drug formulation and quality control. Its technologies are also enabling for other life sciences applications beyond drug discovery, such as environmental-related testing, and in applied markets such as agriculture and forensics. On November 10, 2008, the Company completed the sale of its Pharmaceutical Development and Quality (PDQ) and AutoTrace product lines.

Officers and directors

Robert C. Bishop Ph.D.
Chairman of the Board
Age: 66
Bio & Compensation - Reuters
E. Kevin Hrusovsky
President, Chief Executive Officer, Director
Age: 47
Bio & Compensation - Reuters
David V. Milligan Ph.D.
Vice Chairman of the Board
Age: 68
Bio & Compensation - Reuters
Peter F. McAree
Chief Financial Officer, Senior Vice President
Age: 44
Bio & Compensation - Reuters
David M. Manyak Ph.D.
Executive Vice President - Caliper Discovery Alliances & Services Business Unit
Age: 56
Bio & Compensation - Reuters
Stephen E. Creager
Senior Vice President, General Counsel, Secretary
Portrait. Age: 55
Bio & Compensation - Reuters
Paula J. Cassidy
Senior Vice President - Human Resources
Portrait. Age: 40
Bio & Compensation - Reuters
William C. Kruka
Senior Vice President - Corporate Business Development, Head - Imaging Business Unit
Portrait. Age: 48
Bio & Compensation - Reuters
Bruce J. Bal
Senior Vice President - Operations
Portrait. Age: 50
Bio & Compensation - Reuters
Enrique Bernal
Senior Vice President - In Vitro Business Development
Age: 70
Bio & Compensation - Reuters